{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:51:13Z","timestamp":1791319873338,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jneuroim.2026.579017","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T06:32:22Z","timestamp":1782714742000},"page":"579017","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Diabetes mellitus exacerbates myasthenia gravis by upregulating CD40 expression on B cells through the RAGE\u2013HIF-1\u03b1\u2013HK2 pathway"],"prefix":"10.1016","volume":"419","author":[{"given":"Jing","family":"Dong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-lin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-yue","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-li","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-sheng","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2026.579017_bb0005","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s40259-020-00443-w","article-title":"Monoclonal antibody-based therapies for myasthenia gravis","volume":"34","author":"Alabbad","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3233\/JND-170294","article-title":"New pathways and therapeutic targets in autoimmune myasthenia gravis","volume":"5","author":"Behin","year":"2018","journal-title":"J Neuromuscul Dis"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0015","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.neurol.2017.03.020","article-title":"Expression of receptor for advanced glycation end-products (RAGE) in thymus from myasthenia patients","volume":"173","author":"Bouchikh","year":"2017","journal-title":"Rev. Neurol. (Paris)"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0020","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cyto.a.23305","article-title":"OMIP-043: identification of human antibody secreting cell subsets","volume":"93","author":"Carrell","year":"2018","journal-title":"Cytometry A"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1399-0039.1990.tb01795.x","article-title":"CD40: a cytokine receptor in search of a ligand","volume":"36","author":"Clark","year":"1990","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0030","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fimmu.2020.01582","article-title":"The effects of type 2 diabetes mellitus on organ metabolism and the immune system","volume":"11","author":"Daryabor","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0035","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0040","doi-asserted-by":"crossref","first-page":"7867","DOI":"10.4049\/jimmunol.175.12.7867","article-title":"IL-21 induces differentiation of human naive and memory B cells into antibody-secreting plasma cells","volume":"175","author":"Ettinger","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0045","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2353\/ajpath.2008.071008","article-title":"Sex differences in autoimmune disease from a pathological perspective","volume":"173","author":"Fairweather","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13046-020-01629-4","article-title":"Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma","volume":"39","author":"Feng","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0055","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nrneurol.2016.44","article-title":"Myasthenia gravis - autoantibody characteristics and their implications for therapy","volume":"12","author":"Gilhus","year":"2016","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0060","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0065","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/cmi.2012.61","article-title":"TLR signaling in B-cell development and activation","volume":"10","author":"Hua","year":"2013","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0070","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.4049\/jimmunol.166.11.6893","article-title":"Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4","volume":"166","author":"Im","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0075","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1038\/s41598-019-44358-1","article-title":"Activation of the unfolded protein response in high glucose treated endothelial cells is mediated by methylglyoxal","volume":"9","author":"Irshad","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0080","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0003-4975(00)01595-2","article-title":"Myasthenia gravis: recommendations for clinical research standards. Task force of the medical scientific advisory board of the Myasthenia Gravis Foundation of America","volume":"70","author":"Jaretzki","year":"2000","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0085","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","article-title":"Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus","volume":"49","author":"Jenks","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0090","doi-asserted-by":"crossref","first-page":"6008","DOI":"10.1038\/s41598-018-24529-2","article-title":"Impact of diabetes mellitus on the risk of end-stage renal disease in patients with systemic lupus erythematosus","volume":"8","author":"Jiang","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0095","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/mus.25162","article-title":"B-cell-activating factor is elevated in serum of patients with myasthenia gravis","volume":"54","author":"Kang","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.clim.2017.03.003","article-title":"CD4(+) FoxP3(+) T regulatory cell subsets in myasthenia gravis patients","volume":"179","author":"Kohler","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0105","first-page":"215","article-title":"CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis","volume":"6","author":"Laman","year":"1998","journal-title":"Dev. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1084\/jem.20161590","article-title":"Antibody-secreting plasma cells persist for decades in human intestine","volume":"214","author":"Landsverk","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2022.109141","article-title":"Diabetes mellitus aggravates humoral immune response in myasthenia gravis by promoting differentiation and activation of circulating Tfh cells","volume":"245","author":"Li","year":"2022","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0120","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jnc.14267","article-title":"Hexokinase 2-dependent hyperglycolysis driving microglial activation contributes to ischemic brain injury","volume":"144","author":"Li","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0125","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/(SICI)1097-4598(200004)23:4<453::AID-MUS3>3.0.CO;2-O","article-title":"Acetylcholine receptors and myasthenia","volume":"23","author":"Lindstrom","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0130","article-title":"Type 2 diabetes mellitus as a possible risk factor for myasthenia gravis: a case-control study","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0135","doi-asserted-by":"crossref","first-page":"13084","DOI":"10.3390\/ijms160613084","article-title":"Roles of B cell-intrinsic TLR signals in systemic lupus erythematosus","volume":"16","author":"Ma","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0140","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/leu.2016.211","article-title":"Differentiation stage of myeloma plasma cells: biological and clinical significance","volume":"31","author":"Paiva","year":"2017","journal-title":"Leukemia"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0145","doi-asserted-by":"crossref","unstructured":"Rehling, T., Bj\u00f8rkman, A. D., Andersen, M. B., Ekholm, O. & Molsted, S. Diabetes is associated with musculoskeletal pain, osteoarthritis, osteoporosis, and rheumatoid arthritis. J. Diabetes Res. 2019, 6324348 (2019). doi:https:\/\/doi.org\/10.1155\/2019\/6324348.","DOI":"10.1155\/2019\/6324348"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.610964","article-title":"The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis","volume":"13","author":"Rodr\u00edguez Cruz","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0155","article-title":"Next generation sequencing of cerebrospinal fluid B cell repertoires in multiple sclerosis and other neuro-inflammatory diseases-a comprehensive review","volume":"11","author":"Ruschil","year":"2021","journal-title":"Diagnostics (Basel)"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02458","article-title":"Challenges and opportunities for consistent classification of human B cell and plasma cell populations","volume":"10","author":"Sanz","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0165","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3587::AID-IMMU3587>3.0.CO;2-Y","article-title":"Differential requirements for CD28 and CD40 ligand in the induction of experimental autoimmune myasthenia gravis","volume":"28","author":"Shi","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0170","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s001250051591","article-title":"Advanced glycation end-products: a review","volume":"44","author":"Singh","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0175","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/gerona\/62.4.427","article-title":"Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging","volume":"62","author":"Uribarri","year":"2007","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0180","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/cei.12272","article-title":"Serum cytokine and chemokine profiles in patients with myasthenia gravis","volume":"176","author":"Uzawa","year":"2014","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/jnnp-2014-309232","article-title":"Serum high mobility group box 1 is upregulated in myasthenia gravis","volume":"86","author":"Uzawa","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/srep25886","article-title":"Changes in inflammatory cytokine networks in myasthenia gravis","volume":"6","author":"Uzawa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0195","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fnins.2018.00930","article-title":"Impact of metabolic syndrome on Neuroinflammation and the blood-brain barrier","volume":"12","author":"Van Dyken","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0200","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cytogfr.2013.04.003","article-title":"The BAFF\/APRIL system: emerging functions beyond B cell biology and autoimmunity","volume":"24","author":"Vincent","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0205","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1038\/ni.2511","article-title":"Innate B cell helpers reveal novel types of antibody responses","volume":"14","author":"Vinuesa","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jneuroim.2026.579017_bb0210","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001087","article-title":"Intrathymic plasmablasts are affected in patients with myasthenia gravis with active disease","volume":"8","author":"Yamamoto","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"10.1016\/j.jneuroim.2026.579017_bb0215","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1186\/s12974-021-02298-6","article-title":"Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity","volume":"18","author":"Zhang","year":"2021","journal-title":"J. Neuroinflammation"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572826001669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:58:50Z","timestamp":1791316730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572826001669"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0165572826001669"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579017","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes mellitus exacerbates myasthenia gravis by upregulating CD40 expression on B cells through the RAGE\u2013HIF-1\u03b1\u2013HK2 pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2026.579017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"579017"}}